BIOVIC B — Biovica International AB Share News
0.000.00%
Last trade - 00:00- SEK88.74m
- SEK43.18m
- SEK13.38m
Brief: Biovica International Reports Q3 Net Sales Of SEK 3.29 Mln
Brief: Biovica International CEO Anders Rylander To Step Down During 2026
Brief: Biovica International Publishes PDM-MBC Study Results
Brief: Biovica International Chairman Buys SEK 9.8 Million Of Shares
Brief: Biovica International Q2 Sales SEK 2.675 Million
Brief: Biovica International Signs Client Bill Deal With US Cancer Center
Brief: Biovica International Q1 Sales SEK 2.596 Million
Brief: Biovica Carries Out Directed Share Issue Of SEK 42 Mln
Brief: Biovica Wins SEK 3 Mln Order With Tier 1 Pharma Company
Brief: Biovica International Is Granted New Patent By European Patent Office
Brief: Biovica International Q4 Sales SEK 2.332 Million
Brief: Biovica Signs Agreement With Fifth Tier-1 US Biopharma Company
Brief: Biovica Resolves On Fully Guaranteed Rights Issue
Brief: Biovica Secures Three New Work Orders In Pharma Services Of SEK 2.5 Mln
Brief: Biovica Gets Service Deal And First Study Work Order Of SEK 4 Mln
Brief: Biovica Enters Collaboration Agreement With Tempus
Brief: Biovica International Q3 Sales SEK 2.261 Million
Brief: Biovica And Outcomes4me Partner To Support Metastatic Breast Cancer Patients
Brief: Biovica Secures SEK 2.5 Mln Work Order For TKA Testing